Stockholm - Free Realtime Quote SEK
Guard Therapeutics International AB (publ) (GUARD.ST)
13.65
-0.30
(-2.15%)
As of 10:48:40 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expense
87,996
100,244
114,922
113,629
81,283
Operating Income
-87,996
-100,244
-114,922
-113,629
-81,283
Net Non Operating Interest Income Expense
1,385
3,840
1,750
137
19
Pretax Income
-87,204
-96,066
-113,323
-112,839
-82,030
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-87,204
-96,066
-113,323
-112,839
-82,030
Diluted NI Available to Com Stockholders
-87,204
-96,066
-113,323
-112,839
-82,030
Basic EPS
-8.62
-8.62
-11.26
-16.01
-18.50
Diluted EPS
-8.62
-8.62
-11.26
-16.01
-18.50
Basic Average Shares
11,150.09
11,150.09
10,061.62
7,047.26
4,461.61
Diluted Average Shares
11,150.09
11,150.09
10,061.62
7,047.26
4,461.61
Total Operating Income as Reported
-88,147
-99,905
-115,073
-114,921
-81,900
Total Expenses
87,996
100,244
114,922
113,629
81,283
Net Income from Continuing & Discontinued Operation
-87,204
-96,066
-113,323
-112,839
-82,030
Normalized Income
-87,204
-96,066
-113,323
-112,839
-82,030
Interest Income
1,393
3,848
2,197
138
20
Interest Expense
8
8
447
1
1
Net Interest Income
1,385
3,840
1,750
137
19
EBIT
-87,196
-96,058
-112,876
-112,838
-82,029
EBITDA
-87,196
-96,058
-112,876
-112,838
-82,029
Reconciled Cost of Revenue
0
0
0
0
0
Net Income from Continuing Operation Net Minority Interest
-87,204
-96,066
-113,323
-112,839
-82,030
Normalized EBITDA
-87,196
-96,058
-112,876
-112,838
-82,029
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 4/3/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LIDDS.ST LIDDS AB (publ)
0.0400
0.00%
QUIA.ST Quia Pharma AB (publ)
0.0094
-3.09%
XINT.ST Xintela AB (publ)
0.3730
-3.87%
DIABIO.ST Diagonal Bio AB (publ)
0.0145
0.00%
ISOFOL.ST Isofol Medical AB (publ)
1.8650
+2.53%
2CUREX.ST 2cureX AB (publ)
2.7300
+17.67%
XSPRAY.ST Xspray Pharma AB (publ)
34.25
-2.14%
CMOTEC-B.ST Scandinavian ChemoTech AB (publ)
2.1000
+2.44%
SCOL.ST Scandion Oncology A/S
0.0165
-9.34%
KAN.ST Kancera AB (publ)
1.0680
-1.48%